Extended Data Table 2 APOE3 and APOE4 carriers studied for regional amyloid or tau brain accumulation by PET and BBB permeability changes by DCE-MRI

From: APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline

  1. a, Participants studied for amyloid brain accumulation; b, participants studied for tau accumulation. FBB, participants who received 18F-Florbetaben; FBP, participants who received 18F-Florbetapir.
Back to article page